Literature DB >> 30502797

Primary Meningeal Rhabdomyosarcoma of the Spinal Cord of a Young Dog with Neuromelanocytosis and Multiple Cutaneous Neurofibromas.

L L Hoon-Hanks1, C B Frank2, E F Edmondson3.   

Abstract

A 7-week-old male black Labrador retriever puppy was presented for post-mortem examination following progressive hindlimb paralysis and multiple masses within the skin. A highly compressive and infiltrative intradural mass was found within the T9-T11 spinal cord. Microscopical and immunohistochemical analysis revealed features compatible with spindle cell rhabdomyosarcoma (RMS). The adjacent spinal cord had numerous melanin-containing cells, arranged in small nodules, predominantly within the grey matter (proposed term of 'micronodular neuromelanocytosis') and the left lateral thorax had multifocal dermal neurofibromas. In this case, the constellation of proliferative/neoplastic lesions represents a unique case presentation with unclear aetiology. Primary canine meningeal RMS of the spinal cord has not been reported previously and represents a novel differential diagnosis for spinal tumours of young dogs. Moreover, such cases should be assessed for the presence of additional congenital abnormalities.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  congenital abnormalities; dog; rhabdomyosarcoma; spinal cord

Mesh:

Year:  2018        PMID: 30502797     DOI: 10.1016/j.jcpa.2018.09.008

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  2 in total

1.  Cutaneous spindle cell tumors with features of peripheral nerve sheath tumors and concurrent cardiac involvement: neurofibromatosis type 1-like presentation in a Labrador Retriever dog.

Authors:  Vittoria Castiglioni; Carla Caielli; Giambattista Guenzi; Federico Sacchini
Journal:  J Vet Diagn Invest       Date:  2022-03-15       Impact factor: 1.569

Review 2.  Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.

Authors:  Sara H Osum; Adrienne L Watson; David A Largaespada
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.